Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.20p
   
  • Change Today:
    -0.30p
  • 52 Week High: 6.00p
  • 52 Week Low: 1.73p
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 215,093
  • Market Cap: £247.85m
  • RiskGrade: 268
  • Beta: 0.25

Regulatory News

Notice of 2024 Annual General Meeting 21-Nov-2024 07:00 RNS
Audited Preliminary Results 2024 06-Nov-2024 07:00 RNS
Commencement of Phase III Paediatric Trial 21-Oct-2024 07:00 RNS
Update on funding 16-Oct-2024 07:00 RNS
Update on funding and preliminary results 01-Oct-2024 07:00 RNS
Progression of patient cohorts in PROTECT Trial 17-Sep-2024 07:00 RNS
Update on funding 27-Aug-2024 07:00 RNS
Trading update for the year ended 30 June 2024 22-Jul-2024 07:01 RNS
Appointment of Nominated Adviser and Sole Broker 22-Jul-2024 07:00 RNS
Launch of new Company Long Term Incentive Plan 04-Jul-2024 14:22 RNS
Appointment of Non-Executive Director 27-Jun-2024 07:00 RNS
Progression of patient cohorts in PROTECT Trial 10-Jun-2024 07:00 RNS
Successful meetings with Paul Ehrlich Institut 03-Jun-2024 07:00 RNS
Further detail from G306 Phase III field trial 07-May-2024 07:00 RNS
Director Resignation 03-Apr-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 5.20p
Change Today -0.30p
% Change -5.45 %
52 Week High 6.00p
52 Week Low 1.73p
Volume 215,093
Shares Issued 4,766.44m
Market Cap £247.85m
Beta 0.25
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.81% below the market average69.81% below the market average69.81% below the market average69.81% below the market average69.81% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Trend
51.33% above the market average51.33% above the market average51.33% above the market average51.33% above the market average51.33% above the market average
59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average
Income Not Available
Growth
55.78% below the market average55.78% below the market average55.78% below the market average55.78% below the market average55.78% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

AGY Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:35 87,480 @ 5.20p
16:35 30,000 @ 5.20p
16:35 24,359 @ 5.20p
16:35 25,641 @ 5.20p
16:35 5,323 @ 5.20p

AGY Key Personnel

CEO Manuel Llobet

Top of Page